NCT07042464

Brief Summary

Subject with sarcopenia get modified poco-poco exercise program for 12 weeks

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

June 20, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 29, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2025

Completed
Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

June 11, 2025

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Sarcopenia Staging (Skeletal Muscle Index)

    Skeletal muscle index

    12 weeks

  • Sarcopenia Staging (Muscle Strength)

    Hand Grip Strength, score in kilograms

    12 weeks

  • Sarcopenia Staging (Physical Performance)

    Short Physical Performance Battery, score in numerical 0-12

    12 weeks

  • Levels of Global DNA Methylation

    Global DNA methylation levels were analyzed using the ELISA-based kit

    12 weeks

  • Levels of Growth Differentiation Factor 15

    Growth Differentiation Factor 15 were analyzed the Quantikine ELISA Human GDF-15 Immunoassay

    12 weeks

Study Arms (1)

Modified poco-poco exercises

EXPERIMENTAL

Participants performed modified poco-poco exercises three times weekly for 12 weeks and were assessed, including sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15

Procedure: Modified poco-poco exercises

Interventions

Participants performed modified poco-poco exercises three times weekly for 12 weeks

Modified poco-poco exercises

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 60 years old
  • Have sarcopenia (based on AWGSOP 2019 criteria)

You may not qualify if:

  • Hearing impairment/loss hindering participants to receive verbal instructions
  • Vision impairment/loss hindering participants to receive instructions
  • Musculoskeletal impairment or severe joint diseases (i.e. deformity in Osteoarthritis or Rheumatoid Arthritis)
  • Participants have been involved in other exercise program
  • Severe cardiovascular disease diagnosed by Cardiologist.
  • Participants will be excluded from the research if they skip 3 sessions of the program consecutively or skip 5 sessions cumulatively

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasan Sadikin General Hospital

Bandung, Indonesia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All research subjects received modified poco-poco exercise program for 12 weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 11, 2025

First Posted

June 29, 2025

Study Start

June 20, 2025

Primary Completion

September 20, 2025

Study Completion

September 20, 2025

Last Updated

May 6, 2026

Record last verified: 2026-04

Locations